Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5263184

O=C(O)C(F)(F)F.O=c1[nH]cccc1C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.47
DAO P14920 1/20 0.42
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AURKA O14965 1/20 0.38
AURKB Q96GD4 1/20 0.38
INCENP Q9NQS7 1/20 0.38
PARP1 P09874 1/20 0.38
PPARG P37231 1/20 0.38
GAA P10253 3/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.36
MAOB P27338 2/20 0.35
MCL1 Q07820 1/20 0.35
NFKB1 P19838 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL908781 0.89 KDM4E (0.47) NAPRTDAOKDM4ESMN1; SMN2HSD17B10
Trifluoroacetic Acid SCHEMBL17595211 0.79 NAPRT (0.79) NAPRTDAOKDM4EAURKAAURKB
SCHEMBL29700994 0.73 NOTUM (0.45) DAOKDM4ESMN1; SMN2HSD17B10AURKA
Trifluoroacetic Acid SCHEMBL12495925 0.72 TSHR (0.47) NAPRTKDM4ESMN1; SMN2GAALMNA
Trifluoroacetic Acid SCHEMBL27924721 0.72 NAPRT (0.38) NAPRTDAOKDM4EGAAMAOB
Trifluoroacetic Acid SCHEMBL5264519 0.72 FKBP5 (0.64) NAPRTDAOKDM4EGAA
SCHEMBL24879524 0.69 DAO (0.48) NAPRTDAOKDM4EHSD17B10AURKA
Trifluoroacetic Acid SCHEMBL3642493 0.69 TSHR (0.44) SMN1; SMN2GAALMNAMAOBMAOA
SCHEMBL6984148 0.69 DAO (0.52) NAPRTDAOKDM4EAURKAAURKB
Trifluoroacetic Acid SCHEMBL5801588 0.68 GAA (0.43) HSD17B10PPARGGAALMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869045-A1 NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES AstraZeneca AB (SE) 2007-12-26 EP disclosed
WO-2006107254-A1 NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES ASTRAZENECA AB (SE) 2006-10-12 WO disclosed